C
Cocrystal Pharma D
D
COCP
1.60000
USD
-0.05
(-3.03%)
مغلق
حجم التداول
118
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
16,278,064
العنوان: Cocrystal Pharma
القطاع: Healthcare
الصناعة: Biotechnology
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).